What Does a Multi-Dose Series Mean for the COVID-19 Vaccination Effort? February 5, 2021 Issue Brief This issue brief examines key issues related to multi-dose vaccination series generally as well as issues specific to COVID-19.
Data as of February 1 on State Vaccinations by Race/Ethnicity February 3, 2021 News Release Updated analysis of state-reported data as of February 1, 2021 on COVID-19 vaccinations, cases, and deaths by race/ethnicity is now available. Based on nearly half of states reporting vaccination data by race/ethnicity, Black and Hispanic people continue to receive smaller shares of vaccinations compared to their shares of cases and…
Vaccine Monitor: Where People are Getting Information About COVID-19 Vaccinations February 3, 2021 News Release Additional Data Available Through Online Vaccine Monitor Dashboard As vaccination efforts ramp up across the country, the KFF COVID-19 Vaccine Monitor examines where the public is getting its relevant information. Large shares of the public report that they are getting at least a fair amount of vaccine information from television…
COVID-19 Now Leading Cause of Death in the United States February 2, 2021 Slide In January 2021, the number of deaths from COVID-19 increased so rapidly that it has clearly become the number one cause of death in the U.S., with an average of more than 3,000 people per day dying of COVID-19 in the U.S. as of Jan. 26. Learn more in this Chart of the Week from the Peterson-KFF Health System Tracker.
This Week in Coronavirus: January 22 to January 28 January 29, 2021 Blog During the 53rd week since the first coronavirus case appeared in the United States, the world surpassed 100 million COVID-19 cases, with the United States accounting for a quarter of them. The U.S. also accounts for one-fifth (433,200) of the world’s nearly 2.2 million reported deaths.
Analyzing Recent Trends in Medicaid/CHIP Applications: What We Do and Do Not Know January 28, 2021 Issue Brief This data note discusses changes in the number of applications for Medicaid/CHIP coverage during the coronavirus pandemic. Although enrollment in Medicaid/CHIP has increased steadily by more than 6 million individuals (9%) from February to September 2020, the total number of Medicaid/CHIP applications has decreased by more than 150,000 (-6%) in the same time period. The decline in applications might on the surface suggest that fewer people are applying for coverage even in the face of large job and income losses, but data limitations – in particular, the fact that application statistics do not distinguish between new signups and renewals – make it difficult to draw any clear conclusions.
Vaccine Monitor: Nearly Half of the Public Wants to Get a COVID-19 Vaccine as Soon as They Can or Has Already Been Vaccinated, Up across Racial and Ethnic Groups Since December January 27, 2021 News Release Most Convincing Messages to Promote Vaccination Highlight Effectiveness at Preventing Illness and a Return to Normal Life; Hearing about Rare Allergic Reactions and Side Effects May Discourage Some New KFF Dashboard Features Key Data and Insights from the Vaccine Monitor With millions of Americans getting their first COVID-19 vaccinations, the…
Racial Diversity within COVID-19 Vaccine Clinical Trials: Key Questions and Answers January 26, 2021 Issue Brief This brief reviews why racial diversity within COVID-19 vaccine clinical trials is important, discusses the barriers to participation in clinical trials among people of color, and examines the racial/ethnic composition of clinical trial participants for the Pfizer-BioNTech and Moderna vaccines.
How Quickly We Need To Ramp Up Vaccinations To Get To Herd Immunity January 26, 2021 Perspective Debate about how many vaccinations are needed by when has been in the news. Drew Altman lays it out in his latest column.
Key Issues for State Medicaid Programs When the COVID-19 Public Health Emergency Ends January 25, 2021 Issue Brief As a result of the COVID-19 Public Health Emergency (PHE) , states have experienced increased enrollment along with administrative challenges. After the PHE ends, states are likely to have renewal and redetermination backlogs and will face decisions around continuing temporary policy changes. This brief highlights key issues from the new CMS guidance to states on how to unwind emergency authorities and resume normal eligibility and enrollment operations.